These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6276726)

  • 21. A study of naloxone with schizophrenic and manic patients.
    Sethi BB; Prakash R
    Br J Psychiatry; 1981 Jun; 138():501-3. PubMed ID: 7028200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite.
    Post RM; Uhde TW; Wolff EA
    Acta Psychiatr Scand Suppl; 1984; 313():104-20. PubMed ID: 6367365
    [No Abstract]   [Full Text] [Related]  

  • 23. Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.
    Murphy BL; Ravichandran C; Babb SM; Cohen BM
    J Clin Psychopharmacol; 2014 Dec; 34(6):749-51. PubMed ID: 25310199
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of narcotics and narcotic antagonists on affective disorders, schizophrenia and serum neurohormones.
    Judd LL; Janowsky DS
    Mod Probl Pharmacopsychiatry; 1981; 17():213-25. PubMed ID: 6120452
    [No Abstract]   [Full Text] [Related]  

  • 25. [Administration of naloxone in schizophrenic psychoses and manic syndromes].
    Verhoeven WM; van Praag HM; de Jong JT
    Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical studies on the role of endorphins in schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacologic studies of beta-endorphin in psychopathology.
    Berger PA; Barchas JD
    Psychiatr Clin North Am; 1983 Sep; 6(3):377-91. PubMed ID: 6316299
    [No Abstract]   [Full Text] [Related]  

  • 29. [Endogenous opioids and gamma type endorphins in schizophrenia].
    Verhoeven WM
    Arch Neurobiol (Madr); 1983; 46(5):335-8. PubMed ID: 6362599
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 31. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
    [No Abstract]   [Full Text] [Related]  

  • 32. [The possibility of endorphins playing a role in psychic disturbances].
    Emrich HM
    Arzneimittelforschung; 1978; 28(8):1270-3. PubMed ID: 223579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone effects on manic symptoms and growth-hormone levels.
    Janowsky D; Judd L; Huey L; Roitman N; Parker D; Segal D
    Lancet; 1978 Aug; 2(8084):320. PubMed ID: 79114
    [No Abstract]   [Full Text] [Related]  

  • 34. Naltrexone in the management of heroin addiction: critique of the rationale.
    Goldstein A
    NIDA Res Monogr; 1976 Sep; (9):158-61. PubMed ID: 187941
    [No Abstract]   [Full Text] [Related]  

  • 35. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog.
    Pace NL; Wong KC
    Anesth Analg; 1979; 58(1):36-9. PubMed ID: 219728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lithium in periodic psychoses. Report on 10 years in 34 persons].
    Beloncle M; Martin A; Masson JM; Voisinet C
    Ann Med Psychol (Paris); 1982 Mar; 140(3):369-74. PubMed ID: 6814321
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases].
    Bakharev VD; Tikhomirov SM
    Sov Med; 1984; (6):50-3. PubMed ID: 6147020
    [No Abstract]   [Full Text] [Related]  

  • 38. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone in chronic schizophrenia. Results of a clinical trial.
    Ragheb M; Berney S; Ban T
    Int Pharmacopsychiatry; 1980; 15(1):1-5. PubMed ID: 6993401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research and development of naltrexone: a new narcotic antagonist.
    Julius DA
    Am J Psychiatry; 1979 Jun; 136(6):782-6. PubMed ID: 220890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.